87 related articles for article (PubMed ID: 31391080)
1. Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1.
Garcia E; Hayden A; Birts C; Britton E; Cowie A; Pickard K; Mellone M; Choh C; Derouet M; Duriez P; Noble F; White MJ; Primrose JN; Strefford JC; Rose-Zerilli M; Thomas GJ; Ang Y; Sharrocks AD; Fitzgerald RC; Underwood TJ;
Sci Rep; 2016 Sep; 6():32417. PubMed ID: 27600491
[TBL] [Abstract][Full Text] [Related]
2. Fibroblasts derived from oesophageal adenocarcinoma differ in DNA methylation profile from normal oesophageal fibroblasts.
Smith E; Palethorpe HM; Hayden AL; Young JP; Underwood TJ; Drew PA
Sci Rep; 2017 Jun; 7(1):3368. PubMed ID: 28611465
[TBL] [Abstract][Full Text] [Related]
3. Open chromatin profiling identifies AP1 as a transcriptional regulator in oesophageal adenocarcinoma.
Britton E; Rogerson C; Mehta S; Li Y; Li X; ; Fitzgerald RC; Ang YS; Sharrocks AD
PLoS Genet; 2017 Aug; 13(8):e1006879. PubMed ID: 28859074
[TBL] [Abstract][Full Text] [Related]
4. Tumour microenvironment influences response to treatment in oesophageal adenocarcinoma.
Belle CJ; Lonie JM; Brosda S; Barbour AP
Front Immunol; 2023; 14():1330635. PubMed ID: 38155973
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathways in the development and treatment of oesophageal cancer.
Walker RC; Underwood TJ
Best Pract Res Clin Gastroenterol; 2018; 36-37():9-15. PubMed ID: 30551862
[TBL] [Abstract][Full Text] [Related]
6. The Use of miRNAs in Predicting Response to Neoadjuvant Therapy in Oesophageal Cancer.
Lang CCJ; Lloyd M; Alyacoubi S; Rahman S; Pickering O; Underwood T; Breininger SP
Cancers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267476
[TBL] [Abstract][Full Text] [Related]
7. Analysing the Combined Effects of Radiotherapy and Chemokine Receptor 5 Antagonism: Complementary Approaches to Promote T Cell Function and Migration in Oesophageal Adenocarcinoma.
Davern M; O' Donovan C; Donlon NE; Mylod E; Gaughan C; Bhardwaj A; Sheppard AD; Bracken-Clarke D; Butler C; Ravi N; Donohoe CL; Reynolds JV; Lysaght J; Conroy MJ
Biomedicines; 2024 Apr; 12(4):. PubMed ID: 38672174
[TBL] [Abstract][Full Text] [Related]
8. Potential of damage associated molecular patterns in synergising radiation and the immune response in oesophageal cancer.
Donlon NE; Davern M; Sheppard A; O'Connell F; Moran B; Nugent TS; Heeran A; Phelan JJ; Bhardwaj A; Butler C; Ravi N; Donohoe CL; Lynam-Lennon N; Maher S; Reynolds JV; Lysaght J
World J Gastrointest Oncol; 2023 Aug; 15(8):1349-1365. PubMed ID: 37663943
[TBL] [Abstract][Full Text] [Related]
9. PI3K inhibition as a novel therapeutic strategy for neoadjuvant chemoradiotherapy resistant oesophageal adenocarcinoma.
Edge SD; Renard I; Pyne E; Li C; Moody H; Roy R; Beavis AW; Archibald SJ; Cawthorne CJ; Maher SG; Pires IM
Br J Radiol; 2021 Mar; 94(1119):20201191. PubMed ID: 33434085
[TBL] [Abstract][Full Text] [Related]
10. Combination effect of lapatinib with foretinib in HER2 and MET co-activated experimental esophageal adenocarcinoma.
Hassan MS; Williams F; Awasthi N; Schwarz MA; Schwarz RE; Li J; von Holzen U
Sci Rep; 2019 Nov; 9(1):17608. PubMed ID: 31772236
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of NHE-3 (SLC9A3) expression by MicroRNAs in intestinal epithelial cells.
Anbazhagan AN; Priyamvada S; Kumar A; Jayawardena D; Borthakur A; Gill RK; Alrefai WA; Dudeja PK; Saksena S
Am J Physiol Cell Physiol; 2022 Dec; 323(6):C1720-C1727. PubMed ID: 36189974
[TBL] [Abstract][Full Text] [Related]
12. miR-623 Targets Metalloproteinase-1 and Attenuates Extravasation of Brain Metastatic Triple-Negative Breast Cancer Cells.
Hammash D; Mahfood M; Khoder G; Ahmed M; Tlili A; Hamoudi R; Harati R
Breast Cancer (Dove Med Press); 2022; 14():187-198. PubMed ID: 35936987
[TBL] [Abstract][Full Text] [Related]
13. Hsa-miR-330-5p Aggravates Thyroid Carcinoma via Targeting FOXE1.
Wang Y; Liu Z; Ren X; Sun N; Li Q; Bian C
J Oncol; 2021; 2021():1070365. PubMed ID: 34306074
[TBL] [Abstract][Full Text] [Related]
14. CircLRP6 contributes to prostate cancer growth and metastasis by binding to miR-330-5p to up-regulate NRBP1.
Qin L; Sun X; Zhou F; Liu C
World J Surg Oncol; 2021 Jun; 19(1):184. PubMed ID: 34158077
[TBL] [Abstract][Full Text] [Related]
15. Circular RNA hsa_circ_0001666 sponges miR‑330‑5p, miR‑193a‑5p and miR‑326, and promotes papillary thyroid carcinoma progression via upregulation of ETV4.
Qi Y; He J; Zhang Y; Wang L; Yu Y; Yao B; Tian Z
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33760216
[TBL] [Abstract][Full Text] [Related]
16. Circular RNA circSEMA5A promotes bladder cancer progression by upregulating ENO1 and SEMA5A expression.
Wang L; Li H; Qiao Q; Ge Y; Ma L; Wang Q
Aging (Albany NY); 2020 Nov; 12(21):21674-21686. PubMed ID: 33176280
[TBL] [Abstract][Full Text] [Related]
17. Impact of Deoxycholic Acid on Oesophageal Adenocarcinoma Invasion: Effect on Matrix Metalloproteinases.
Quilty F; Byrne AM; Aird J; El Mashad S; Parra-Blanco A; Long A; Gilmer JF; Medina C
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126685
[TBL] [Abstract][Full Text] [Related]
18. Silencing miR-202-3p increases MMP-1 and promotes a brain invasive phenotype in metastatic breast cancer cells.
Harati R; Hafezi S; Mabondzo A; Tlili A
PLoS One; 2020; 15(10):e0239292. PubMed ID: 33002044
[TBL] [Abstract][Full Text] [Related]
19. Silencing microRNA-330-5p increases MMP1 expression and promotes an invasive phenotype in oesophageal adenocarcinoma.
Bibby BAS; Miranda CS; Reynolds JV; Cawthorne CJ; Maher SG
BMC Cancer; 2019 Aug; 19(1):784. PubMed ID: 31391080
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
